Fibromyalgia and hepatitis C virus chronic infection: Lack of association in two samples;Fibromialgia e infecção crônica pelo vírus da hepatite C: Ausência de associação em duas amostras

Revista Brasileira de Reumatologia

Volumn 47, Issue 2, 2007, Pages 97-105

  Ribeiro, Luiz Severiano ^a,c   Coelho, Austenir Maciel ^a   de Pádua, Ana Flávia Madureira ^a   Dias, Leandro Lamas ^a   Azevedo, Daniela Castelo ^a   Moura, Fabiana de Miranda ^a   Mendes, Guilherme Santiago ^a   Miranda, Helder Chaia Toledo ^a   Proietti, Fernando Augusto ^b  

^a Hospital Governador Israel Pinheiro (HGIP IPSEMG)   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c NONE   (Brazil)

Author keywords

Fibromyalgia; Hepatitis C virus; Infection

Indexed keywords

AUTOANTIBODY; THYROID ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FATIGUE; FEMALE; FIBROMYALGIA; GASTROENTEROLOGY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL PAIN; OUTPATIENT DEPARTMENT; PARESTHESIA; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PREVALENCE; RAYNAUD PHENOMENON; RNA ANALYSIS; SJOEGREN SYNDROME;

EID: 51449110197     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0482-50042007000200004     Document Type: Article

References (55)

1. Thomas DL, Lemon SM: Hepatitis C. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases, 5th ed. Philadelphia, Churchill Livingstone; 1736-60, 2000.
2. Choo Q-L, Koo G, Weiner AI, et al: Isolation of a cDNA clone derived from a blood-born non-A, non-B viral hepatitis genome. Science 244: 359-64, 1989.
3. Staub HL: Vírus C da hepatite, manifestações sistêmicas e o reumatologista. Rev Bras Reumatol 38: 139-46, 1998.
4. Alter MJ: Epidemiology of hepatitis C in the West. Semin Liver Dis 15: 5-14, 1995.
5. Alter MJ, Kruszon-Moran D, Nainan OV, et al: The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 19: 556-62, 1999.
6. Bassit L, Santos GR, Silva LC, et al: Genotype distribution of hepatitis C virus in São Paulo, Brazil: rare subtype found. Hepatology 29: 994-5, 1999.
7. Wener MH, Johnson RJ, Sasso EH, Gretch DR. Hepatitis C virus and rheumatic disease (Editorial). J Rheumatol 23: 953-9, 1996.
8. Lovy MR, Starkebaum G, Uberoi S: Hepatitis C infection presenting with rheumatic manifestations: a mimic of rheumatoid arthritis. J Rheumatol 23: 979-83, 1996.
9. Liu F, Knight GB, Agnello V: Hepatitis C virus but not GB virus C/ hepatitis G virus has a role in type II cryoglobulinemia. Arthritis Rheum 42: 1898-901, 1999.
10. Kerr GS, Rofail M, Lewis JH, et al: Prevalence of hepatitis C virus associated cryoglobulinemia at a Veterans Hospital. J Rheumatol 24: 2134-8, 1997.
11. Ferri C, Zignego AL: Relation between infection and autoimmunity in mixed cryoglobulinemia. Curr Opin Rheumatol 12: 53-60, 2000.
12. Daghestani L, Pomeroy C: Renal manifestations of hepatitis C infection. Am J Med 106: 347-54, 1999.
13. Vassilopoulos D, Calabrese LH: Rheumatic manifestations of hepatitis C infection. Curr Rheumatol Rep 5: 200-4, 2003.
14. Killemberg PG: Extrahepatic manifestations of chronic hepatitis C. Semin Gastrointest Dis 11: 62-8, 2000.
15. Cacoub P, Poynard T, Ghillani P, et al: Extrahepatic manifestations of chronic hepatitis C. Arthritis Rheum 42: 2204-12, 1999.
16. Font J, Ramos-Casals M, Garcia-Carrasco M, et al: Hepatitis C virus infection in systemic lupus erythematosus. Study in a series of 134 patients. Arthritis Rheum 43: s251, 2000.
17. Barbosa VS, Silva NA, Martins RMB: Soroprevalência e genótipos do vírus da hepatite C em pacientes corn lúpus eritematoso sistêmico (LES) em Goiânia, Brasil. Rev Bras Reumatol 45: 201-5, 2005.
18. Rivera J, De Diego A, Trinchet M, Garcia Monforte A: Fibromyalgia associated hepatitis C virus infection. Br J Rheumatol 36: 981-5, 1997.
19. Buskila D, Shnaider A, Neumann L, et al: Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients. Semin Arthritis Rheum 28: 107-13, 1998.
20. Buskila D, Shnaider A, Neumann L, Zilberman D, Hilzenrat N, Sikuler E: Fibromyalgia in hepatitis C virus infection. Arch Intern Med 157: 2497-500, 1997.
21. Poynard T, Cacoub P, Ratziu V, et al: Fatigue in patients with chronic hepatitis C. J Viral Hepatitis 9: 295-303, 2002.
22. Gouding C, O'Connell P, Murray FE: Prevalence of fibromyalgia, anxiety and depression in chronic hepatitis C virus infection: relationship to RT-PCR status and mode of acquisition. Eur J Gastroenterol Hepatol 13: 507-11, 2001.
23. Loureiro M, Belloto E, Christmann RM, et al: Prevalêcia de fibromialgia em pacientes infectados com o vírus C da hepatite. Rev Bras Reumatol 42: 37-41, 2002.
24. Ribeiro LS, Proietti FA: Interrelations between fibromyalgia, thyroid autoantibodies, and depression. J Rheumatol 31: 2036-40, 2004.
25. Bittencourt RJ, Chaves SK Amado RC, et al: Validação de inquérito de risco referido para vigilância em saúde de fatores de risco de doença arterial coronariana em servidores públicos estaduais de Juiz de Fora, Minas Gerais, Brasil. Cad Saúde Pública 20: 761-70, 2004.
26. Wolfe F, Smythe HA, Yunnus MB, et al: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 33: 160-72, 1990.
27. Haun MVA, Ferraz MB, Pollak DF: Validação dos critérios do Colégio Americano de Reumatologia (1990) para classificação da fibromialgia em uma população brasileira. Rev Bras Reumatol 39: 221-30, 1998.
28. Maillefert JF, Muller G, Falgarone G, et al: Prevalence of hepatitis C virus infection in patients with rheumatoid arthritis. Ann Rheum Dis 61: 635-7, 2000.
29. Lawrence RC, Helmick CG, Arnett PC, et al: Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 41: 778-99, 1998.
30. Arnett FC, Edworthy SM, Bloch DA, et al: The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 31: 315-24, 1988.
31. Hochberg MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40: 1725, 1997.
32. Vitali C, Bombardieri S, Jonsson R, et al: Classification criteria for Sjögren's Syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61: 554-8, 2002.
33. Wilson WA, Gharavi AE, Koike T, et al: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42: 1309-11, 1999.
34. Masi AT, Rodnan GP, Medsger TA Jr, et al: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23: 581-90, 1980.
35. Wortmann RL: Inflammatory diseases of muscle and other myopathies. In: Kelley WN, Harris Jr. ED, Ruddy S, Sledge CB, editors. Textbook of Rheumatology, 5th ed. Philadelphia: WB Saunders, 1997. pp. 1177-206,
36. Hunder GG: Giant cell arteritis and polymyalgia rheumatica. In: Kelley WN, Harris Jr. ED, Ruddy S, Sledge CB, editors. Textbook of Rheumatology, 5th ed. Philadelphia: WB Saunders, 1997. pp. 1123-32.
37. Hochberg MC: Relapsing polychondritis. In: Kelley WN, Harris Jr. ED, Ruddy S, Sledge CB, editors. Textbook of rheumatology, 5th ed. Philadelphia: WB Saunders, 1997. pp. 1404-8.
38. International Study Group for Behçet's Disease: Criteria for diagnosis of Behçet's disease. Lancet 335: 1078-80, 1990.
39. Sheehan DV, Lecrubier Y, Sheehan KH, et al: The MINI-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD 10. J Clin Psychiatry 59 (Suppl20): 22-33, 1998.
40. American Psychiatric Association: Diagnostic and statistical manual of mental disorders. 3th edition, revised (DSM-III-R). Washington DC: American Psychiatric Association, 1987.
41. American Psychiatric Association: Diagnostic and statistical manual of mental disorders. 4th edition (DSM-IV). Washington DC: American Psychiatric Association, 1994.
42. World Health Organization: International Classification of Diseases. 10th revision. Genebra: WHO, 1992.
43. Amorim P: MINI International neuropsychiatric Interview (MINI): validação de entrevista breve para diagnóstico de transtornos mentais. Rev Bras Psiquiatr 22: 106-15, 2000.
44. Dean AG, Dean JA, Coulombier D, et al: Epi Info. Version 6.0: a word processing database and statistics program for epidemiology on microcomputers. Atlanta: centers for Disease Control and Prevention, 1994.
45. StataCorp Stata Statistical Software: Release 8.2. College Station. TX: Stata Corporation, 2005.
46. Ribeiro LS, Proietti FA: Fibromialgia e estresse infeccióso: possíveis associações entre a síndrome de fibromialgia e infecções viróticas crônicas. Rev Bras Reumatol 45: 20-9, 2005.
47. Narváez J, Nolla JM, Valverde-Garcia J: Lack of association of fibromyalgia with hepatitis C virus infection. J Rheumatol 32: 1118-21, 2005.
48. Macfarlane GJ, Morris S, Hunt IM, et al: Chronic widespread pain in the community: the influence of psychological symptoms and mental disorder on healthcare seeking behavior. J Rheumatol 26: 413-9, 1999.
49. Okfuji O, Turk DC, Sherman JJ: Evaluation of the relationship between depression and fibromyalgia syndrome: why aren't all patients depressed? J Rheumatol 27: 212-9, 2000.
50. Aaron LA, Bradley LA, Alarcón GS, et al: Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness. Arthritis Rheum 39: 436-45, 1996.
51. Vorcaro CMR, Lima-Costa MFF, Barreto SM, Uchoa E: Unexpected high prevalence of 1-month depression in a small Brazilian community. The Bambuí Study. Acta Psychiatr Scand 104: 257-68, 2001.
52. Larsen PR, Davies TF, Hay ID: The thyroid gland. In: Wilson JD, Foster DW, kronenberg HM, Larsen PF, editors. Williams Textbook of endocrinology, 9th edition. Philadelphia: WB Sauders, 1998. pp. 389-515.
53. Wacholder S, McLaughlin JK, Silverman DT, Mandel JS: Selection of controls in case-control studies I. Principles. Am J Epidemiol 135: 1019-28, 1992.
54. Wacholder S, Silverman DT, McLaughlin JK, Mandel JS: Selection of controls in case-control studies II. Types of controls. Am J Epidemiol 135: 1029-41, 1992.
55. Wacholder S, Silverman DT, McLaughlin JK, Mandel JS: Selection of controls in case-control studies III. Design options. Am J Epidemiol 135: 1042-50, 1992.